Cargando…

A new immune checkpoint-associated nine-gene signature for prognostic prediction of glioblastoma

Glioblastoma (GBM) is a highly malignant neurological tumor that has a poor prognosis. While pyroptosis affects cancer cell proliferation, invasion and migration, function of pyroptosis-related genes (PRGs) in GBM as well as the prognostic significance of PRGs remain obscure. By analyzing the mechan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jin, Xiao, Zhao, Xiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	5700
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981394/ https://www.ncbi.nlm.nih.gov/pubmed/36862886 http://dx.doi.org/10.1097/MD.0000000000033150

Ejemplares similares

Identification of hub gene and lncRNA signature related to entotic cell death in cutaneous melanoma for prognostic and immune prediction
por: Zhang, Chen, et al.
Publicado: (2023)

A novel Anoikis and immune-related genes marked prognostic signature for colorectal cancer
por: Cai, Zhiqiang, et al.
Publicado: (2022)

Cuproptosis-related prognostic signatures predict the prognosis and immunotherapy in HCC patients
por: Peng, Hong, et al.
Publicado: (2023)

A novel risk signature with 6 RNA binding proteins for prognosis prediction in patients with glioblastoma
por: Huang, Qian-Rong, et al.
Publicado: (2021)

Prognostic significance and immune infiltration of microenvironment-related signatures in pancreatic cancer
por: Lu, Qian, et al.
Publicado: (2021)

Integrative radiogenomic analysis for genomic signatures in glioblastomas presenting leptomeningeal dissemination
por: You, Hye Jin, et al.
Publicado: (2016)

Immune-related lncRNA pairs as novel signature to predict prognosis and immune landscape in melanoma patients
por: Li, Zhehong, et al.
Publicado: (2022)

Integrated analysis identifies an immune-based prognostic signature for the mesenchymal identity in colorectal cancer
por: Zhang, Bin, et al.
Publicado: (2020)

Establishment of immune prognostic signature and analysis of prospective molecular mechanisms in childhood osteosarcoma patients
por: Zhang, Zide, et al.
Publicado: (2020)

A 17-gene expression-based prognostic signature associated with the prognosis of patients with breast cancer: A STROBE-compliant study
por: Qian, Jin-Xian, et al.
Publicado: (2020)

A prognostic signature associated with cell senescence predicts survival outcomes and strongly associates with immunotherapy and chemotherapy response in breast cancer
por: Pan, Tao, et al.
Publicado: (2023)

A novel anoikis-related gene signature predicts prognosis in patients with breast cancer and reveals immune infiltration
por: Tang, Chaoyi, et al.
Publicado: (2023)

Construction of a 6-gene prognostic signature to assess prognosis of patients with pancreatic cancer
por: Yang, Jiayue, et al.
Publicado: (2020)

Identification and prognostic value of a glycolysis-related gene signature in patients with bladder cancer
por: Wu, Zhengyuan, et al.
Publicado: (2021)

Construction and validation of a prognostic model for tongue cancer based on three genes signature
por: Tan, Haosheng, et al.
Publicado: (2023)

Identification of a basement membrane-related genes signature to predict prognosis, immune landscape and guide therapy in gastric cancer
por: Liu, Zhi-Yang, et al.
Publicado: (2023)

Construction and validation of a robust ferroptosis-associated gene signature predictive of prognosis in lung adenocarcinoma
por: Zhou, Mi, et al.
Publicado: (2022)

Integrative network analysis identifies an immune-based prognostic signature as the determinant for the mesenchymal subtype in epithelial ovarian cancer
por: Sheng, Mingyan, et al.
Publicado: (2020)

Bioinformatics analysis of the prognostic and clinical value of senescence-related gene signature in papillary thyroid cancer
por: Wen, Tingting, et al.
Publicado: (2023)

A five-gene signature for predicting overall survival of esophagus adenocarcinoma
por: Lan, Tian, et al.
Publicado: (2021)

Immune-related adverse events with immune checkpoint inhibitors: Special reference to the effects on the lungs
por: Hirata, Aya, et al.
Publicado: (2021)

A novel gene signature derived from the CXC subfamily of chemokine receptors predicts the prognosis and immune infiltration of patients with lung adenocarcinoma
por: Deng, Kun, et al.
Publicado: (2022)

Prognostic implications of an autophagy-based signature in colorectal cancer
por: Wang, Liangbin, et al.
Publicado: (2021)

A promising prognostic signature for lung adenocarcinoma (LUAD) patients basing on 6 hypoxia-related genes
por: Luo, Jie, et al.
Publicado: (2021)

Prediction and analysis of hub genes between glioblastoma and low-grade glioma using bioinformatics analysis
por: Xu, Baowei
Publicado: (2021)

Isocitrate Dehydrogenase (IDH)1/2 Mutations as Prognostic Markers in Patients With Glioblastomas
por: Chen, Jun-Rui, et al.
Publicado: (2016)

Study on the gene signature related to immune microenvironment on viral and nonviral infections of hepatocellular carcinoma
por: Qian, Hong, et al.
Publicado: (2021)

Hub gene target of glioblastoma: LOX, SERPINH1 and TGFBI
por: Zhang, Shuyuan, et al.
Publicado: (2022)

Association between systemic immune-inflammation index (SII) and survival outcome in patients with primary glioblastoma
por: Yang, Chao, et al.
Publicado: (2023)

A 3-DNA methylation signature as a novel prognostic biomarker in patients with sarcoma by bioinformatics analysis
por: Wang, Xiao-Wei, et al.
Publicado: (2021)

Immune checkpoint inhibitors are effective in the treatment of Epstein-Barr virus-associated gastric cancer: A case report
por: An, Gaili, et al.
Publicado: (2023)

The mitochondrial energy metabolism pathway-related signature predicts prognosis and indicates immune microenvironment infiltration in osteosarcoma
por: Yang, Sen, et al.
Publicado: (2023)

A seven-m(6)A regulator-related CpG site-based prognostic signature for endometrial carcinoma
por: Zhang, Xiang, et al.
Publicado: (2021)

Identification and verification of a 4-gene signature predicting the overall survival of cervical cancer
por: Yuan, Lu, et al.
Publicado: (2022)

Early analysis of surrogate endpoints for metastatic melanoma in immune checkpoint inhibitor trials
por: Petrelli, Fausto, et al.
Publicado: (2016)

Treatment-related adverse events as surrogate to response rate to immune checkpoint blockade
por: Shen, Yanyun, et al.
Publicado: (2020)

Model establishment of prognostic-related immune genes in laryngeal squamous cell carcinoma
por: Sun, Ming, et al.
Publicado: (2021)

Efficacy of immune checkpoint inhibitors in the treatment of non-small cell lung cancer patients with different genes mutation: A meta-analysis
por: Zhang, Rui, et al.
Publicado: (2021)

Identification of pyroptosis-related gene signature for predicting prognosis of patients with pancreatic cancer using bioinformatics
por: Xu, Zhongbo, et al.
Publicado: (2022)

A novel circadian cycle-related gene signature for prognosis prediction of patients with breast cancer
por: Hu, Yuanyuan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5nbp2hkv99qg6frbjgo7qcf2d5